These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8666273)

  • 1. Retroviral vectors designed for targeted expression of RNA polymerase III-driven transcripts: a comparative study.
    Ilves H; Barske C; Junker U; Böhnlein E; Veres G
    Gene; 1996 Jun; 171(2):203-8. PubMed ID: 8666273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
    Junker U; Böhnlein E; Veres G
    Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter.
    Thompson JD; Ayers DF; Malmstrom TA; McKenzie TL; Ganousis L; Chowrira BM; Couture L; Stinchcomb DT
    Nucleic Acids Res; 1995 Jun; 23(12):2259-68. PubMed ID: 7610054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-polymerase III-driven expression cassettes in human gene therapy.
    Medina MF; Joshi S
    Curr Opin Mol Ther; 1999 Oct; 1(5):580-94. PubMed ID: 11249665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
    Peng H; Callison D; Li P; Burrell C
    Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization.
    Bertrand E; Castanotto D; Zhou C; Carbonnelle C; Lee NS; Good P; Chatterjee S; Grange T; Pictet R; Kohn D; Engelke D; Rossi JJ
    RNA; 1997 Jan; 3(1):75-88. PubMed ID: 8990401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA polymerase III control elements are required for trans-activation by the murine retroviral long terminal repeat sequences.
    Hwang YW; Yoo NK; Yang HM; Choi SY
    Biochem Biophys Res Commun; 2015 Jan; 456(1):110-5. PubMed ID: 25446107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a nonviral vector to express a chimeric tRNA-ribozyme against lymphocytic choriomeningitis virus: cytoplasmic accumulation of a catalytically competent transcript but minimal antiviral effect.
    Gebhard JR; Perry CM; Mahadeviah S; Whitton JL
    Antisense Nucleic Acid Drug Dev; 1997 Feb; 7(1):3-11. PubMed ID: 9055033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
    Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
    Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression and HIV-1 inhibition of chimeric tRNA(Lys3)-ribozymes under dual U6 snRNA and tRNA promoters.
    Chang Z; Westaway S; Li S; Zaia JA; Rossi JJ; Scherer LJ
    Mol Ther; 2002 Oct; 6(4):481-9. PubMed ID: 12377189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized expression of small RNA inhibitors in human cells.
    Paul CP; Good PD; Li SX; Kleihauer A; Rossi JJ; Engelke DR
    Mol Ther; 2003 Feb; 7(2):237-47. PubMed ID: 12597912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3'-End modification of the adenoviral VA1 gene affects its expression in human cells: consequences for the design of chimeric VA1 RNA ribozymes.
    Barcellini-Couget S; Fenard D; Bertrand E; Singer RH; Lefebvre JC; Doglio A
    Antisense Nucleic Acid Drug Dev; 1998 Oct; 8(5):379-90. PubMed ID: 9826265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs.
    Li MJ; Bauer G; Michienzi A; Yee JK; Lee NS; Kim J; Li S; Castanotto D; Zaia J; Rossi JJ
    Mol Ther; 2003 Aug; 8(2):196-206. PubMed ID: 12907142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TFIIIC determines RNA polymerase III specificity at the TATA-containing yeast U6 promoter.
    Roberts S; Colbert T; Hahn S
    Genes Dev; 1995 Apr; 9(7):832-42. PubMed ID: 7705660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter choice affects the potency of HIV-1 specific RNA interference.
    Boden D; Pusch O; Lee F; Tucker L; Shank PR; Ramratnam B
    Nucleic Acids Res; 2003 Sep; 31(17):5033-8. PubMed ID: 12930953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significantly higher activity of a cytoplasmic hammerhead ribozyme than a corresponding nuclear counterpart: engineered tRNAs with an extended 3' end can be exported efficiently and specifically to the cytoplasm in mammalian cells.
    Kuwabara T; Warashina M; Koseki S; Sano M; Ohkawa J; Nakayama K; Taira K
    Nucleic Acids Res; 2001 Jul; 29(13):2780-8. PubMed ID: 11433023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of the CCR5 beta-chemokine receptor and inhibition of HIV-1 infection by stable VA1-ribozyme chimeric transcripts.
    Cagnon L; Rossi JJ
    Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):251-61. PubMed ID: 10984119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.
    Chuah MK; VandenDriessche T; Chang HK; Ensoli B; Morgan RA
    Hum Gene Ther; 1994 Dec; 5(12):1467-75. PubMed ID: 7711139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A variety of RNA polymerases II and III-dependent promoter classes is repressed by factors containing the Krüppel-associated/finger preceding box of zinc finger proteins.
    Senatore B; Cafieri A; Di Marino I; Rosati M; Di Nocera PP; Grimaldi G
    Gene; 1999 Jul; 234(2):381-94. PubMed ID: 10395912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Epstein-Barr virus-encoded small RNA promoters for driving the expression of fusion transcripts harboring short hairpin RNAs.
    Choy EY; Kok KH; Tsao SW; Jin DY
    Gene Ther; 2008 Feb; 15(3):191-202. PubMed ID: 17972920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.